Atlantic International Corp.

NASDAQ:ATLN

Medical - Diagnostics & Research

Healthcare
$0.90 -13.84%

-$0.10 today

Market cap
$73.17M
Beta
0.71
P/E (TTM)
-0.6
EPS (TTM)
-$1.08
52W Low $0.60High $5.25

Volume 18.56M

Average 0.44M

ATLN Total Current Assets

All assets expected to be converted to cash or used up within one year.

Atlantic International Corp.NASDAQ: ATLN

Total Current Assets · Q4 FY2025 · quarter ended Dec 2025

Total current assets falls 7.8% from a year ago

Total current assets stood at $81.2M at the end of Q4 FY2025, down 7.8% from a year earlier and up 13.2% from the prior quarter. Over 3 fiscal years it compounded at +130.4% a year.

Context

  • Total current assets amounted to 71.7% of total assets at the end of Q4 FY2025, unchanged from a year earlier.
  • Total current assets increased in 2 of the last 3 fiscal years.

What to watch

Whether total current assets keeps falling in the next quarterly balance sheet after a -7.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$81.2M+13.2% QoQ
Last fiscal yearDec 2025
$81.2M-7.8% YoY
Year agoDec 2024
$88.02M-7.8% since
Total Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.8%——
1 year-7.8%——
3-year CAGR+130.4%——
5-year CAGR——
10-year CAGR——

Total Current Assets history

USD · from the balance sheet

Latest · FY2025
81.2M USD
Year-over-year change
-7.8%
4-year CAGR
+67.1%

Total Current Assets vs competitors

How ATLN compares with its peers on the latest reported figures

  • ATLN's Dec 2025 total current assets of $81.2M is the 6th highest of the 8 companies compared; the peer median is $134.27M.
  • Its year-over-year change of -7.8% is the 5th highest of 8, against a peer median of +32.9%.
  • Total current assets amounts to 71.7% of total assets for ATLN, versus a peer median of 75.5%.
ATLN Competitors Peer median
Total Current Assets for ATLN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AVRAnteris Technologies Global Corp.Mar 2026$286.67M +441.1%+8.6%97.3%
NKTXNkarta, Inc.Mar 2026$235.89M -13.1%-7.8%63.4%
MISTMilestone Pharmaceuticals Inc.Mar 2026$192.25M +217.9%+15.9%99.2%
PEPGPepGen Inc.Mar 2026$134.27M +32.9%-6.7%85.9%
PREPrenetics Global LimitedMar 2026$132.11M +69.3%-29.9%75.4%
ATLNAtlantic International Corp.Dec 2025$81.2M -7.8%+130.4%71.7%
STIMNeuronetics, Inc.Mar 2026$47.18M -22.2%-14.6%37.6%
IMDXInsight Molecular Diagnostics Inc.Mar 2026$30.52M -15.8%-15.7%75.5%
Peer median (excluding ATLN) $134.27M+32.9%-7.8%75.5%

Competitors are the stored peer set for ATLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents4.02M2.18M1.35M678.68K81.13K
Short-term Investments5.93M4.04M000
Net Receivables65.68K81.21K64.48M73.44M69.99M
Inventory224.16K165.85K000
Other Current Assets003.68M4.7M11.12M
Total Current Assets10.42M6.64M78.8M88.02M81.2M
Property, Plant & Equipment (Net)265.27K1.66M2.8M2.38M3.17M
Goodwill00000
Intangible Assets0036.19M31.4M26.6M
Long-term Investments00000
Tax Assets005.24M00
Other Non-current Assets50.49K118.95K3.64M960.6K2.26M
Total Non-current Assets315.76K1.78M47.87M34.73M32.03M
Total Assets10.74M8.41M126.67M122.75M113.23M
Account Payables871.36K622.44K799.57K2.03M5.11M
Short-term Debt1.38M0138.9M43.88M7.99M
Tax Payables00013.91K1.16M
Deferred Revenue00000
Other Current Liabilities0360.46K011.1M101.84M
Total Current Liabilities2.56M1.23M161.56M97.25M114.95M
Long-term Debt01.38M980.85K36.71M30.37M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities002.18M00
Total Non-current Liabilities02.82M4.46M37.52M30.37M
Total Liabilities2.56M4.05M166.02M134.77M145.32M
Common Stock119119254531557
Retained Earnings(14.41M)(18.51M)(61.8M)(135.48M)(194.91M)
Accumulated OCI022.45K000
Other Stockholders Equity0116000
Minority Interest00000
Total Equity8.18M4.37M(39.35M)(12.02M)(32.09M)
Total Debt1.38M2.93M142.62M82.72M38.36M
Net Debt(2.64M)748.93K141.26M82.04M38.28M

Atlantic International Corp.

NASDAQ:ATLN

Intrinsic Alpha fair value

Locked

Current Price

$0.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.